Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 235 (8%)
Anticipated shortage: 19 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583

Showing 1641 to 1660 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ATORVASTATIN 10MG TABLET To be discontinued 2018-09-07 2018-09-07 60276
APO-CYCLOBENZAPRINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60405
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-ENALAPRIL 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146

Showing 81 to 100 of 356